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The emerging links between our gut microbiome and the central nervous system (CNS)
are regarded as a paradigm shift in neuroscience with possible implications for not only
understanding the pathophysiology of stress-related psychiatric disorders, but also their
treatment. Thus the gut microbiome and its influence on host barrier function is positioned
to be a critical node within the brain-gut axis. Mounting preclinical evidence broadly
suggests that the gut microbiota can modulate brain development, function and behavior
by immune, endocrine and neural pathways of the brain-gut-microbiota axis. Detailed
mechanistic insights explaining these specific interactions are currently underdeveloped.
However, the concept that a “leaky gut” may facilitate communication between the
microbiota and these key signaling pathways has gained traction. Deficits in intestinal
permeability may underpin the chronic low-grade inflammation observed in disorders
such as depression and the gut microbiome plays a critical role in regulating intestinal
permeability. In this review we will discuss the possible role played by the gut microbiota
in maintaining intestinal barrier function and the CNS consequences when it becomes
disrupted. We will draw on both clinical and preclinical evidence to support this concept
as well as the key features of the gut microbiota which are necessary for normal intestinal
barrier function.
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The Gut Microbiome
It is increasingly recognized that the gut microbiome might inﬂuence the core symptoms of
neuropsychiatric disorders and that it might be a tractable target for novel treatment options.
The mutualistic co-evolution of microbes and the human body, composed of more than 90%
microbial cells and 10 million microbial genes has led to the collective being described as a
“superorganism” (Nicholson et al., 2005). The most heavily colonized area of the human body
is the gut, with bacterial concentrations ranging from 101–103 cells per gram in the upper
intestine to 1011–1012 per gram in the colon (O’Hara and Shanahan, 2006; Derrien and van
Hylckama Vlieg, 2015). Although the functional signiﬁcance of the microbiome has yet to
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be fully determined (Franzosa et al., 2014), it is clear that
an interlinked symbiotic relationship exists between host
and microbe (Ley et al., 2008). In terms of bacterial phyla
found in the gut, Firmicutes (species such as Lactobacillus,
Clostridium, Enterococcus) and Bacteroidetes (species such as
Bacteroides) account for the majority (Dethlefsen et al., 2007),
though the other phyla such as Actinobacteria (Biﬁdobacteria),
Proteobacteria (Escherichia coli), Fusobacteria, Verrucomicrobia,
and Cyanobacteria are also present (Eckburg et al., 2005;
Qin et al., 2010). Diﬀerences exist between the microbiota
composition between the gut lumen and the microbiota
composition which lies in close proximity to the mucus layer.
For instance, gram negative Proteobacteria and Akkermansia
muciniphila (Verrucomicrobia), which use mucus as a carbon
and nitrogen source, adhere and reside within the mucus layer
(van Passel et al., 2011). This gradient can be diﬀerentially
regulated by factors such as stress (Rozee et al., 1982; Swidsinski
et al., 2005; Johansson et al., 2011, 2014). A more detailed
examination of the gut microbiota composition is beyond the
scope of this review and the interested reader is directed to a
number of excellent recent reviews on the topic (Bron et al., 2012;
Jeﬀery et al., 2012a; Lozupone et al., 2012; O’Toole, 2012). Studies
using diﬀerent, but complementary, gut-microbiota directed
interventions (Germ Free (GF) rodents, antibiotics, probiotics,
gastrointestinal (GI) infection studies, and fecal microbiota
transplantation studies) have all suggested a number of possible
brain-gut signaling pathways under the inﬂuence of the gut
microbiota and capable of modulating brain and behavior (Rhee
et al., 2009; Grenham et al., 2011; Cryan and Dinan, 2012, 2015;
Collins and Bercik, 2013; Dinan and Cryan, 2013;McVeyNeufeld
et al., 2013; Mayer et al., 2014a). This review will discuss the
complex relationship between the gut microbiome and intestinal
barrier function and examine the possible implications for stress-
related psychiatric disorders.
Development, Structure, and Function of
the Intestinal Epithelial Barrier
The main function of the intestinal barrier is to regulate the
absorption of nutrients, electrolytes and water from the lumen
into the circulation and to prevent the entry of pathogenic
microorganisms and toxic luminal substances (Farhadi et al.,
2003). Furthermore, regulation of the exchange of molecules
between the environment and the host through the intestinal
barrier inﬂuences the equilibrium between tolerance and
immunity to self and non-self-antigens (Fasano and Shea-
Donohue, 2005; Fasano, 2011). From a structural perspective
these functions are preserved by a number of features including
a mucus layer and a monolayer of epithelial cells interconnected
by tight junctions (Madara, 1998). The mucus layer containing
secretory immunoglobulin (Ig) A and antimicrobial peptides
covers the epithelial cell lining which functions to facilitate GI
transport, and as a protective layer against bacterial invasion.
The colonic mucus layer is composed of two layers, an outer
and inner layer composed of gel forming highly glycosylated
proteins termed mucins. These are produced and maintained by
goblet cells which renew the inner mucus layer approximately
every hour (Johansson et al., 2011). These dynamic processes
are subject to extensive and continuous interplay with the gut
microbiota, disruption of which may have implications for the
sustenance of key barrier functions (Yu et al., 2012; Bischoﬀ et al.,
2014).
Tight junctions on the other hand are complex protein
structures that consist of transmembrane proteins such as
claudin, occludin, and tricullulin (Dörfel and Huber, 2012).
These transmembrane proteins connect with the opposing
plasma membrane, thereby forming a mechanical link between
epithelial cells and establishing a barrier to paracellular diﬀusion
of ﬂuid and solutes (Ivanov et al., 2010). The structure of the
intestinal barrier is formed by the end of the ﬁrst trimester
(Montgomery et al., 1999). Epithelial cells with microvilli, goblet
and enteroendocrine cells, appear by week eight of gestation and
tight junctions are detected from week ten (Louis and Lin, 2009).
Functional development of the intestinal barrier continues in
the post natal period and is inﬂuenced by both feeding mode
and diet (Cummins and Thompson, 2002; Verhasselt, 2010).
Disruptions in this process, as exempliﬁed by the underdeveloped
intestinal barrier of the premature infant, can predispose to
immune disorders (Groschwitz and Hogan, 2009). Indeed, there
is an overlapping developmental course of the gut microbiota
and intestinal barrier. The gut microbiota in the initial days of
life is unstable and not particularly diverse in its make-up. By
age three, however, the microbiota composition resembles that of
an adult-like proﬁle (Voreades et al., 2014). Several other factors
may also inﬂuence the trajectory of microbiota development
including gestational age (Barrett et al., 2013), mode of delivery
(Dominguez-Bello et al., 2010), type of feeding (Penders et al.,
2006), antibiotic use (Persaud et al., 2014), and exposure to family
members and pets (Fujimura et al., 2010; Marques et al., 2010).
The intestinal barrier acts as a shield which can be modiﬁed by
the gut microbiota (Tlaskalová-Hogenova et al., 2011; Jakobsson
et al., 2015) or its metabolites (Elamin et al., 2013). The
mechanisms underlying the regulation of the epithelial barrier
are complex. Recent evidence also suggests a novel role for non-
coding RNAs, such asmicroRNAs, as important intermediaries in
the interactions between host epithelial cells, immune cells and
the gut microbiota (Cichon et al., 2014; Runtsch et al., 2014).
Alterations in the gut microbiota have been associated with
concomitant gut barrier dysfunction in both intestinal (Camilleri
et al., 2012; Bonfrate et al., 2013; Scaldaferri et al., 2013) and
extra-intestinal disorders (Vaarala et al., 2008). However, the role
of the gut microbiota in disrupting the intestinal barrier in stress-
related neuropsychiatric conditions, such as depression, has not
been fully investigated.
Microbiome and the Blood Brain Barrier
Structural similarities exist between the intestinal, placental
and blood brain barriers (BBB; Doran et al., 2013). The
BBB is a complex neurovascular unit (Bauer et al., 2014)
consisting of central nervous system (CNS) endothelial cells
which separate the lumen of blood vessels from the CNS
parenchyma. Tight junctions, astrocytes and pericytes seal the
capillary endothelial cells of the BBB (Daneman and Rescigno,
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2009). The tight junctions transmembrane proteins claudins,
tricellulin, and occludin restrict paracellular diﬀusion of water-
soluble substances from blood to the brain (Hawkins and Davis,
2005). Recent preclinical evidence fromGFmice suggests that the
microbiota can modulate the BBB. Exposure of GF adult mice
to the fecal microbiota from pathogen-free donors decreased
BBB permeability and increased the expression of tight junction
proteins (Braniste et al., 2014). Moreover, monocolonization of
the intestine of GF adult mice with short chain fatty acid (SCFA)-
producing bacterial strains normalized BBB permeability whilst
sodium butyrate was associated with increased expression of
occludin in the frontal cortex and hippocampus (Braniste et al.,
2014). This study strengthens the hypothesis that the BBB may
also be vulnerable to changes in the gut microbiota.
Brain-gut-microbiota Axis
Bidirectional signaling between the gut and the brain is regulated
at neural, endocrine, and immune levels. These pathways are
under the inﬂuence of the gut microbiota and together, they
comprise the brain-gut-microbiota axis (Grenham et al., 2011).
A cardinal function of the gut microbiota is the development
and maintenance of the intestinal barrier across the lifespan
(Ohland and Macnaughton, 2010; Swanson et al., 2011; Shifrin
et al., 2012). It is plausible that subtle alterations in microbiota
acquisition or maintenance in early life may act as a vulnerability
factor, impacting on (neuro)endocrine and (neuro)immune
signaling pathways of the brain-gut-microbiota axis, disruption
of which may subsequently predispose to stress-related disorders
in adulthood (Borre et al., 2014). Notably, animals devoid of a
microbiota exhibit reduced levels of anxiety but an exaggerated
neuroendocrine response to stress (Sudo et al., 2004). The
most pronounced impacts of the microbiota may occur early
in life during critical neurodevelopmental phases (Borre et al.,
2014). It is evident that the gut microbiota is required for
the normal development of the hypothalamic pituitary adrenal
(HPA) axis and that there is a certain period in early life
when colonization must occur to ensure normal development
of this critical stress signaling pathway (Sudo et al., 2004;
Moloney et al., 2014). Indeed, this concept is an extension of the
hygiene hypothesis ﬁrst proposed in the late 1980’s (Strachan,
1989) and more recently reconceptualised as the “old friends
hypothesis” (Rook et al., 2003). This proposes that encountering
less microbial biodiversity may contribute to the increase in
chronic inﬂammatory disorders including subtypes of depression
(Klerman and Weissman, 1989; Weissman, 1992; Guarner et al.,
2006; Rook and Lowry, 2008; Hidaka, 2012; Rook et al., 2013,
2014; Williamson et al., 2015).
The interaction between the immune system, the gut
microbiota and the intestinal barrier may be of particular
importance to health at the other extreme of life, aging. Aging
is characterized by chronic low-grade inﬂammation (termed
“inﬂammaging”) as evidenced by increased circulating levels of
Tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6 and C-
reactive protein (CRP); inﬂammatory molecules known to aﬀect
mood and cognition (Frasca and Blomberg, 2015). The fact
that the gut microbiota are key regulators of immune function
and inﬂammatory responses, it is likely that a change in the
composition of the gut microbiota during aging plays a role in
the gradual activation of the immune system and consequently
inﬂammaging (Prenderville et al., 2015), possibly via an impact
on intestinal permeability. Indeed, the ELDERMET consortium
demonstrated that the elderly have a distinct microbiota proﬁle,
characterized by greater inter-individual variation compared to
younger adults (Claesson et al., 2011). Of note, diﬀerences in
microbiota composition were more pronounced between frail
elderly subjects and healthy elderly subjects. Moreover, certain
gut microbiota signatures were linked to measures of frailty,
co-morbidity, nutritional status, and markers of inﬂammation
(Claesson et al., 2012).
Stress, the Gut Microbiota and Barrier
Function
Stress can impact on the developmental trajectory of the
intestinal barrier (Smith et al., 2010; Lennon et al., 2013)
and has been associated with an increase in gut permeability
(Söderholm et al., 2002). Indeed, the eﬀects of stress on intestinal
permeability are complex and likely involve both the gut
and the brain. Corticotrophin releasing factor (CRF) and its
receptors (CRFR1 and CRFR2), play a key role in stress-induced
gut permeability dysfunction (Overman et al., 2012; Rodiño-
Janeiro et al., 2015; Taché and Million, 2015). In response to
an acute stressor, colonic paracellular permeability increases
and has been associated with the development of visceral
hypersensitivity (Ait-Belgnaoui et al., 2005). In a mouse model
of chronic depression, elevated central CRH expression occurred
concomitantly with changes in the gut microbiota (Park et al.,
2013). Early life stress has also been demonstrated to enhance
plasma corticosterone in rat pups and is associated with an
increase in intestinal permeability and bacterial translocation to
the liver and spleen. This eﬀect appeared to predominate in the
colon (Moussaoui et al., 2014). Of note, stress-induced changes in
the HPA axis and autonomic nervous system display sensitivity
to probiotic intervention (Lactobacillus helveticus R0052 and
Biﬁdobacterium longum R0175); (Ait-Belgnaoui et al., 2014).
Moreover, these probiotics also restored colonic tight junction
integrity in stressed mice (Ait-Belgnaoui et al., 2014). Probiotics
have also been demonstrated to inﬂuence bacterial adhesion
and translocation to mesenteric lymph nodes in response to
stress (Zareie et al., 2006). Lactobacillus farciminis in particular
not only suppresses stress-induced changes in permeability,
HPA axis activity, endotoxaemia, and neuroinﬂammation (Ait-
Belgnaoui et al., 2012), but also beneﬁcially inﬂuences the mucus
barrier (Da Silva et al., 2014). Human studies further conﬁrm
that acute-stress paradigms can aﬀect intestinal permeability. In
a public speaking based stressor, small intestinal permeability
was signiﬁcantly increased, however, this was only observed in
those subjects who also responded with a signiﬁcant elevation
of cortisol (Vanuytsel et al., 2014). In a diﬀerent acute stress
model using a cold pain stressor, albumin permeability increased,
though in females only (Alonso et al., 2012).
Stressful early-life events are strongly associated with the
development of depression later in life (Heim et al., 2000).
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The interaction between stress, the HPA axis and the immune
system is well established (Baes et al., 2014; Hueston and Deak,
2014). In recent years it has emerged that the gut microbiota
mediates this interaction (De Palma et al., 2014b). Early-life
maternal separation, for example, results in a signiﬁcant decrease
in fecal Lactobacillus numbers three days post-separation and
this correlated with stress-related behaviors (Bailey and Coe,
1999). In a mouse model of social disruption, stress-induced
alterations in the microbiota were accompanied by changes
in cytokine and chemokine levels (Bailey et al., 2011). Several
other studies have veriﬁed that stress can remodel the gut
microbiota composition (Wang and Wu, 2005; O’Mahony et al.,
2009; Galley et al., 2014a,b; De Palma et al., 2015). This is
also relevant prenatally, as infants of mothers with high self-
reported stress and high salivary cortisol concentrations during
pregnancy had a signiﬁcantly higher relative abundance of
Proteobacteria and lower relative abundances of lactic acid
bacteria (Lactobacillus, Lactoccus,Aerococcus) and Biﬁdobacteria.
However, it is currently unclear whether this eﬀect was mediated
via maternal microbial transmission or through microbiota-
independent events. Nonetheless, those infants with altered
microbiota composition exhibited a higher level of infant GI
symptoms and allergic reactions, highlighting the functional
consequences of aberrant colonization patterns in early life
(Zijlmans et al., 2015). Recent preclinical evidence showed
that maternal stress altered the vaginal microbiota, decreasing
Lactobacillus, with implications for the metabolic proﬁle and
neurodevelopment in the oﬀspring (Jašarevic et al., 2015a,b).
A dysfunctional intestinal barrier could permit a microbiota
driven proinﬂammatory state with implications for the brain
(see Figure 1). The sequence of this process is not yet clear. An
increase in gut permeability could precedemucosal inﬂammation
to induce the inﬂammatory response and thus culminate in a
feed-forward cycle between inﬂammatory responses and barrier
dysfunction. This could subsequently maintain and exacerbate
the low grade inﬂammatory response. Alternatively, systemic
inﬂammation could increase intestinal barrier permeability and
thus allow translocation of commensal bacteria with further
implications for systemic inﬂammation. Indeed, the source of the
low grade inﬂammation which has been reported in depression
has not been isolated to a particular source. Irrespective of
the sequence, both processes could engage the gut microbiota.
Higher IgA- and IgM-mediated immune responses directed
against lipopolysaccharides (LPS) of certain commensal gram
negative gut bacteria have been shown in depressed patients
(Maes et al., 2008, 2012). The implication being that the presence
of such responses may have occurred subsequent to disruption of
the intestinal barrier. Moreover, bacterial DNA has been detected
in whole serum from depressed patients who also displayed
increased Toll-like receptor (TLR)-4 expression on peripheral
mononuclear blood cells compared to healthy controls (Kéri
et al., 2014). To date, two published cross sectional studies
have investigated the gut microbiota composition in depression.
The ﬁrst found an increase in Bacteroidales and a decrease
in Lachnospiraceae compared to controls. However, there were
no signiﬁcant diﬀerences in species richness, α-diversity, or
operational taxonomic units (Naseribafrouei et al., 2014). In
the second study increased levels of Enterobacteriaceae and
Alistipes were observed. Moreover, Fecalibacterium levels were
reduced in the depressed group and negatively correlated with
severity of depressive symptoms (Jiang et al., 2015). In the
context of alcohol abuse, a relationship between the microbiota,
barrier function and comorbid depression has recently been
reported (Leclercq et al., 2014a). Microbiota-derived LPS and
peptidoglycans (PGN) were demonstrated to cross the gut barrier
and activate their respective receptors, TLR4 and TLR2 in
peripheral blood mononuclear cells. Although chronic alcohol
consumption inhibited the NF-κB pathway, it activated protein
kinase/activator protein 1 pathway and IL-8 and IL-1B. In
contrast, short term alcohol withdrawal was associated with the
recovery of TLR4 receptors. The same group also demonstrated
that increased intestinal permeability occurred in a sub group
of alcohol-dependent subjects which were associated with higher
depression and anxiety scores as well as an altered gut microbiota
proﬁle (Leclercq et al., 2014b).
Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a stress-related functional
brain-gut-microbiota axis disorder associated with an altered
gut microbiota proﬁle (Carroll et al., 2011; Jeﬀery et al., 2012c;
Collins, 2014; De Palma et al., 2014a; Simrén, 2014; Soares,
2014; Rajilic-Stojanovic et al., 2015) and increased intestinal
permeability (Dunlop et al., 2006; Rao et al., 2011; Camilleri et al.,
2012). Moreover, a signiﬁcant proportion of IBS patients also
suﬀer from depressive and anxiety symptoms (Singh et al., 2012;
Lucas et al., 2014); furthermore, these psychiatric symptoms
increase with the greater frequency and severity of GI symptoms
(Pinto-Sanchez et al., 2015). In addition, alterations in brain
circuits involved in attention, emotion, pain (Labus et al.,
2009; Blankstein et al., 2010; Tillisch et al., 2013) together
with deﬁcits in hippocampal-mediated visuospatial memory
(Kennedy et al., 2012, 2014) have been noted in the disorder.
In particular, an altered Firmicutes: Bacteroidetes ratio has
been linked to IBS and an association between Firmicutes,
Proteobacteria and IBS symptom scores has been demonstrated
(Rajilic-Stojanovic et al., 2011). A recent meta-analysis of
clinical studies to identify and assess the various diagnostic
tests indicated that a combination of intestinal permeability,
Rome I criteria and fecal calprotectin (see Table 1) provided
the highest positive likelihood ratio for predicting IBS (Sood
et al., 2015). Although not captured in this meta-analysis,
and not part of routine clinical practice, the addition of gut
microbiota proﬁling may deliver further diagnostic accuracy
(Casen et al., 2015). For example, IBS subtypes have been
stratiﬁed according to their microbiota proﬁles, speciﬁcally those
with an increased Firmicutes: Bacteroidetes ratio (Jeﬀery et al.,
2012b). Furthermore, depression was the most robust clinical
discriminator between a high Firmicutes: Bacteroidetes ratio
in IBS patients relative to IBS patients with a healthy-like
microbiota signature (Jeﬀery et al., 2012b). In addition, the order
Actinomycetales and the family Actinomycetaceae were inversely
associated with clinically signiﬁcant depression (Jeﬀery et al.,
2012b).
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FIGURE 1 | The brain-gut-microbiota axis. Postulated signaling pathways between the gut microbiota, the intestinal barrier and the brain. A dysfunctional intestinal
barrier or “leaky gut” could permit a microbiota-driven proinflammatory state with implications for neuroinflammation.
Although the microbiota varies along the length of the
gastrointestinal tract, the majority of studies use fecal microbiota
sampling as a representative of global changes, however
site speciﬁc changes may inﬂuence the ensuing immune
consequences. For example mucosal jejunal tissue from diarrhea-
predominant IBS patients is also associated with increased
activation of mucosal B lymphocytes, plasma cells and mucosal
IgG production (Vicario et al., 2015). Of note in this study,
humoral activity markers positively correlated with depressive
symptoms (Vicario et al., 2015). Further studies need to be
conducted to disentangle the contributing role of an exaggerated
or aberrant immune response, changes in intestinal permeability
and psychiatric co-morbidities in IBS. However, individuals
with pre-existing psychological disorders are known to be
at an increased risk of developing post-infectious IBS (PI-
IBS) in particular (Thabane and Marshall, 2009). Variations
in several genes associated with bacterial recognition, the
inﬂammatory response and epithelial integrity including TLR9,
IL-6 and cadherin 1 genes have been identiﬁed as risk factors
for the development of PI-IBS (Craig and Quigley, 2010;
Villani et al., 2010). A longitudinal study which examined
the rate of IBS development following an accidental outbreak
of E. coli 0157:H7 into a town’s (Walkerton) water supply
identiﬁed an increased rate of IBS two years after the outbreak
(Marshall, 2009). A subsequent study further identiﬁed a modest
increase in intestinal permeability amongst this IBS cohort
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TABLE 1 | Markers of intestinal permeability.
Permeability test Sample Measures Clinical/Preclinical Representative citation
CHALLENGE TESTS
Lactulose/Mannitol Urine Small intestine permeability Clinical and preclinical Vanuytsel et al., 2014
Lactulose/L-rhamnose Urine Small intestine permeability Clinical and preclinical Keszthelyi et al., 2014
Sucrose Urine Gastric permeability Clinical and preclinical Mujagic et al., 2014
Sucralose Urine Colonic permeability Clinical and preclinical Anderson et al., 2004
Polyethylene glycols Urine Entire intestine permeability Clinical and preclinical Rao et al., 2011
51Cr-EDTA Urine Entire intestine permeability Clinical and preclinical Grootjans et al., 2010
CIRCULATING MARKERS
Zonulin Plasma Small intestine epithelial cell damage Clinical and preclinical Fasano, 2011
Intestinal fatty acid binding protein (I-FABP) Plasma Small intestine permeability Clinical and preclinical Derikx et al., 2009
Citrulline Plasma Small intestine epithelial cell damage Clinical and preclinical Crenn et al., 2000
αGlutathione S-transferase (αGST) Plasma Epithelial cell damage Clinical and preclinical McMonagle et al., 2006
Claudin-3 Urine Epithelial cell damage Clinical and preclinical Patel et al., 2012
Lipopolysacharide Binding protein (LBP) Plasma Indirect evidence of permeability deficit Clinical and preclinical Pasternak et al., 2010
Endotoxin core antibodies (EndoCAb) Plasma Entire intestine permeability Clinical and preclinical Ammori et al., 2003
D-Lactate Plasma Entire intestine permeability Clinical and preclinical Poeze et al., 1998
Fluorescein isothiocyanate—dextran
(FITC-Dextran 4)
Plasma Entire intestine permeability Preclinical Moussaoui et al., 2014
FECAL MARKERS
Calprotectin Feces Nonspecific marker of gut inflammation Clinical and preclinical de Magistris et al., 2010
Zonulin Feces Marker of intestinal permeability Clinical Lamprecht et al., 2012
EX VIVO
Ussing chamber Ex vivo biopsies Tranepithelial electrical resistance and
macromolecule flux
Clinical and preclinical Piche et al., 2009
(Marshall et al., 2004); an association between this outbreak
and depression was also identiﬁed (Garg et al., 2006). However,
whether there is an association between a deﬁcient barrier and the
onset of depressive-like symptoms amongst this cohort has yet to
be determined. Similarly, an outbreak of Shiga toxin-producing
E. coli O104 in Germany increased self-reported depressive and
anxiety symptomsmeasured six months after the infection (Löwe
et al., 2014). However, intestinal permeability was not measured
in this study.
Independent of the emergence of IBS following a GI infection,
sickness behaviors and depressive like behaviors are notable
consequences of peripheral infections (Dantzer et al., 2008).
Several enteric pathogens have been shown to have a detrimental
eﬀect on the intestinal barrier (Paesold et al., 2002; Berkes
et al., 2003; Flynn and Buret, 2008) which can occur via
paracellular (Ferrier et al., 2003; Wu et al., 2011) or transcellular
routes (Kalischuk et al., 2009). It is well established that
GI infection produces elevated anxiety-like behavior in mice
(Lyte et al., 2006). Antibiotics can also alter the diversity
of the composition of the gut microbiota (Dethlefsen and
Relman, 2011; Willing et al., 2011) with potential implications
for neurochemistry and behavior (Bercik and Collins, 2014).
In addition, certain antibiotics may have an adverse eﬀect
on the intestinal barrier. For example, rats administered oral
clindamycin for four days, followed by oral infection with
Salmonella enteritidis showed increased intestinal permeability
as measured by 24 h urinary CrEDTA compared to the
uninfected control group (van Ampting et al., 2010). Similarly,
inﬂammatory bowel disease (IBD), a GI disease characterized
by overt inﬂammation, is also associated with intestinal barrier
dysfunction (Laukoetter et al., 2008; Marchiando et al., 2010;
Antoni et al., 2014) increased intestinal permeability (Gerova
et al., 2011) immune dysregulation and an altered gut microbiota
(Sartor and Mazmanian, 2012). IBD is also associated with a
higher prevalence of anxiety and depressive disorders (Walker
et al., 2008). Moreover, stress can adversely aﬀect the course
of IBD (Mittermaier et al., 2004; Mawdsley and Rampton,
2005). Both Crohn’s disease and ulcerative colitis exhibit
alterations in the expression of the tight junction proteins,
claudin and occludin (Heller et al., 2005; Zeissig et al., 2007).
Interestingly, recent preclinical evidence suggests that chronic
intestinal inﬂammation alters hippocampal neurogenesis (Zonis
et al., 2015) which itself in inﬂuenced by the gut microbiota
(Ogbonnaya et al., 2015).
Candidate Pathways to Barrier Dysfunction
Serotonin
Serotonin is a critical signaling molecule in the brain-gut-
microbiota axis (O’Mahony et al., 2015) and is involved in a
wide range of physiological functions. In the GI tract it plays
an important role in secretion, sensing and signaling (Mawe
and Hoﬀman, 2013). The largest reserve of 5-HT is located in
enterochromaﬃn cells (Berger et al., 2009). Emerging evidence
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also suggests that the serotonergic system may be under the
inﬂuence of gut microbiota, especially, but not limited to, periods
prior to the emergence of a stable adult-like gut microbiota
(Desbonnet et al., 2008; El Aidy et al., 2012; Clarke et al., 2013).
Mucosal 5-HT has been demonstrated to play a direct role in
the regulation of intestinal permeability. 5-hydroxytryptophan
(5-HTP), a precursor of 5HT, signiﬁcantly decreased intestinal
permeability in healthy control subjects and this was associated
with a redistribution of ZO-1. Whilst in IBS patients 5-HTP
resulted in a further decrease in occludin expression (Keszthelyi
et al., 2014). The gut microbiota itself is also an important, but
frequently overlooked, regulator of 5-HT synthesis and secretion.
For example, colonic tryptophan hydroxylase 1 (Tph1) mRNA
and protein were increased in humanized GF and conventionally
raised mice. Bacterial metabolites have also been demonstrated
to inﬂuence Tph1 transcription in a human enterochromaﬃn
cell model (Reigstad et al., 2015). Others have demonstrated
that distinct microbial metabolites produced by spore forming
bacteria increase colonic and blood 5-HT in chromaﬃn cell
cultures (Yano et al., 2015).
Toll-like Receptors
Toll-like receptors (TLRs) are evolutionarily conserved type I
transmembrane proteins that function as pattern recognition
receptors (PRRs) and recognize microbial components (Pålsson-
McDermott and O’Neill, 2007; Mogensen, 2009; McCusker and
Kelley, 2013). TLRs recognize microbe-associated molecular
patterns (MAMPs) which are shared by many microorganisms.
TLRs are expressed by a number of immune cells, including
dendritic cells (DCs), macrophages, neutrophils, T cells, and
B cells but are also found on non-immune cells, such as
epithelial and endothelial cells (Hopkins and Sriskandan, 2005).
Activation of TLRs initiates signal transduction pathways and
triggers the expression of genes that control innate immune
responses and further guide development of antigen-speciﬁc
acquired immunity (Akira and Takeda, 2004). Thus, TLRs might
serve as a molecular channel between microbiota alterations
and immune homeostasis (Rogier et al., 2015). As well as
playing a role in maintaining intestinal barrier function (Cario
et al., 2004; Rakoﬀ-Nahoum et al., 2004), TLRs also promote
epithelial cell proliferation, secretion of IgA into the gut
lumen and expression of antimicrobial peptides (Abreu, 2010).
Dysregulation of these processes, or excessive TLR activation,
can result in chronic inﬂammatory and over-exuberant repair
responses. Recent evidence suggests that the TLR3 synthetic
agonist, Poly(I:C) not only decreases epithelial resistance in the
small intestine but also promoted thinning of the mucosal layer
(Moyano-Porcile et al., 2015).
Short Chain Fatty Acids
The microbiota produces several bioactive metabolic products,
including polysaccharides, lycosylceramides, nucleic acids,
structural proteins, and SCFAs (Olle, 2013; Russell et al., 2013).
SCFAs (butyrate, acetate, and propionate) are neurohormonal
signaling molecules produced by certain classes of bacteria
such as Bacteroides, Biﬁdobacterium, Propionibacterium,
Eubacterium, Lactobacillus, Clostridium, Roseburia, and
Prevotella (Macfarlane and Macfarlane, 2012). SCFAs are
transported by monocarboxylate transporters, which notably
are expressed at the BBB (Steele, 1986; Vijay and Morris,
2014). Indeed a recent preclinical imaging study demonstrated
that microbiota-derived acetate can cross the BBB where it
can subsequently alter hypothalamic gene expression (Frost
et al., 2014). SCFAs are also pivotal in the maintenance of
the intestinal barrier (Peng et al., 2007), with physiological
concentrations having demonstrable eﬀects on intestinal barrier
function (Suzuki et al., 2008). Butyrate has been demonstrated
to inﬂuence expression of tight junction proteins including
claudin-2, occludin, cingulin, and zonula occludens proteins
(ZO-1, ZO-2; Plöger et al., 2012). Butyrate has also been shown
to facilitate the association between transcription factors and the
claudin-1 promoter (Wang et al., 2012a), increase AMP-activated
protein kinase (AMPK) activity (Peng et al., 2009) and to reduce
bacterial translocation (Lewis et al., 2010). Interestingly, given
the importance of butyrate in the maintenance of the intestinal
barrier, IBS has been associated with a reduction in butyrate
producing gut micro-organisms (Pozuelo et al., 2015). It
has, however, proven diﬃcult thus far to demarcate the CNS
consequences of SCFA-mediated eﬀects on intestinal barrier
function from a direct action in the brain. It is also notable
that there is still considerable debate surrounding the ability of
physiological levels of SCFAs to impact substantially on relevant
behaviors via central mechanisms, albeit that higher doses
do have clear behavioral consequences (MacFabe et al., 2007;
Macfabe, 2012).
Other mechanisms by which the microbiota may signal to
the underlying mucosa, or mucosal immune system, include
delivery to an underlying subset of dendritic cells via small
intestine goblet cells (Artis, 2008; McDole et al., 2012). It has
also been postulated that bacterial components can cross the
intestinal barrier in small lipoprotein vesicles called exosomes
which contain protein, nucleic acids, sugars and lipids. These
exosomes can then transfer from dendritic cells to T cells in the
draining lymph nodes and enter the circulation (Smythies and
Smythies, 2014b). Consequently, T cells may receive epigenetic
material from gut bacteria, either by direct endocytosis, or
via aﬀerent exosomes (Smythies and Smythies, 2014a). More
recently, identiﬁcation of “neuropods” as a pathway by which
bacteria can communicate via intestinal enterochromaﬃn cells
to the nervous system provides further insight into pathways
responsible for gut to brain communication (Bohórquez et al.,
2015).
Restoration and Maintenance of a Healthy
Intestinal Barrier
Diet, composition of the gut microbiota and health are
intrinsically linked (Daniel et al., 2014; David et al., 2014).
Diets consisting of fast food and processed food have been
associated with increased intestinal permeability and depressive
symptoms (Sánchez-Villegas et al., 2012). Conversely, diets
rich in vegetables, fruit and ﬁsh are associated with lower
depressive symptoms (Akbaraly et al., 2009; Jacka et al.,
2010, 2011, 2014; Ruusunen et al., 2014). Both preclinical
and clinical studies show that dietary components can alter
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intestinal permeability (Cani et al., 2008; Ulluwishewa et al.,
2011; Stenman et al., 2012; Teixeira et al., 2012; Hamilton et al.,
2015). In particular, high fat diets are associated with a greater
translocation of LPS across the gut wall (Moreira et al., 2012).
Moreover, meals rich in ﬁber and fruit have been demonstrated
to reduce high fat/high carbohydrate meal-induced increases
in plasma LPS levels, the inﬂammatory response and the
expression of TLR2 and TLR4 (Ghanim et al., 2009). High
fat diets can also inﬂuence the gut microbiota and have been
demonstrated to increase the Firmicutes: Bacteriodetes ratio and
induce the growth of Enterobacteriaceae (Kim et al., 2012).
This eﬀect was accompanied by increased plasma and fecal
endotoxin levels and reduced expression of the tight junction
proteins claudin-1 and occludin in the colon (Kim et al.,
2012). High fat diet-induced increases in LPS translocation
and barrier function are also sensitive to restoration by
organisms such as Akkermansia muciniphila (Everard et al.,
2013).
Pre- and Pro-biotics
A probiotic is deﬁned as a live bacteria which when administered
in adequate amounts confers a health beneﬁt on the host (WHO,
2001; Petschow et al., 2013). Although, previous probiotic
health claims have been exaggerated (Shanahan, 2002; Sanders,
2003; Hoﬀmann et al., 2013) it is clear that certain strains
demonstrate beneﬁcial eﬀects on the intestinal barrier across the
lifespan via a number of mechanisms and mediators (Eutamene
and Bueno, 2007; Mennigen and Bruewer, 2009). The term
“psychobiotics” has been recently conceived to encompass the
sub-types of probiotics that may be capable of modulating the
brain-gut-microbiota axis to have a beneﬁcial eﬀect on mood,
anxiety and cognition (Dinan et al., 2013). However, despite
Logan and Katzman’s initial proposal of an augmenting role of
probiotics in depression (Logan and Katzman, 2005), there are
currently no published studies of the clinical use of probiotics
in depressed patients. One double-blind, placebo-controlled trial
of probiotic supplementation conducted in patients diagnosed
with schizophrenia, failed to show superiority over placebo
supplementation (Dickerson et al., 2014). Several studies have
been conducted in the healthy population (see Table 3). In
the context of primarily non-psychiatric disorders (see also
Table 3), B. lactis augmented formula, fed to preterm infants,
resulted in decreased intestinal permeability as measured by
the lactulose/mannitol ratio at two, seven and 30 days post
birth (Stratiki et al., 2007). In a double-blinded, placebo-
controlled, cross-over study L. rhamnosus 19070-2 and L.
reuteri DSM 12246 were administered for six weeks to 41
children with moderate and severe atopic dermatitis. This
probiotic combination decreased associated GI symptoms and
inﬂuenced small intestinal permeability as measured by the
lactulose–mannitol test (Rosenfeldt et al., 2004). In healthy
adults L. plantarum WCFS1 administered to the duodenum
via feeding catheter, increased ZO-1 and occludin compared to
placebo. In the in vitro arm of the same study L. plantarum
induced translocation of ZO-1 to the tight junction region
in human epithelium, though the authors point out that the
eﬀects on occludin were minor compared with those seen
in vivo. Furthermore, L. plantarum was shown to activate TLR2
signaling (Karczewski et al., 2010). In a randomized, double-
blinded, placebo controlled trial, a 14 week course of probiotic
supplementation in athletes resulted in a decrease in fecal zonulin
(see Table 1) in the probiotic group compared to the control
group after a period of intense exercise measured at baseline and
at 14 weeks (Lamprecht et al., 2012).
Some of the strongest evidence for the clinical role of
probiotics comes from studies in patients with the brain-gut-
axis disorder, IBS (Whelan and Quigley, 2013; Orel and Kamhi
Trop, 2014). A number of probiotics and commensal organisms,
primarily lactic acid bacteria, have been shown to ameliorate
certain IBS symptoms (Hoveyda et al., 2009; Clarke et al., 2012;
Ortiz-Lucas et al., 2013; Yoon et al., 2014; Didari et al., 2015).
Some of these beneﬁcial eﬀects may, at least, relate to the
anti-inﬂammatory eﬀects of particular organisms (O’Mahony
et al., 2005). Moreover, probiotics in accordance with preclinical
evidence (see Table 2) can improve intestinal barrier function
under pathological conditions in human populations. In a
randomized single blind placebo controlled study a fermented
milk drink containing Streptococcus thermophilus, L. bulgaricus,
L. acidophilus, and B. longum decreased small intestinal
permeability, though colonic permeability was unaltered (Zeng
et al., 2008).
A prebiotic eﬀect is deﬁned as the selective stimulation
of growth and/or activity(ies) of one or a limited number
of microbial genus(era)/species in the gut microbiota that
confer(s) health beneﬁts to the host (Gibson, 2004; Roberfroid
et al., 2010). Preclinical and clinical studies demonstrate that
certain prebiotics alter the gut microbiota, can reduce low
grade inﬂammation and improve metabolic function (Everard
et al., 2011; Greiner and Bäckhed, 2011; da Silva et al.,
2013; Dewulf et al., 2013; Bindels et al., 2015). Evidence
also suggests that prebiotic galacto-oligosaccharides (GOS) can
improve intestinal barrier function in rats (Zhong et al., 2009).
Moreover, mice treated with prebiotics exhibit improvements
in intestinal permeability, tight junction integrity, decreased
plasma LPS and cytokine levels in addition to decreased
hepatic expression of inﬂammatory and oxidative stress markers
(Cani et al., 2009). Prebiotics have also been shown to
inﬂuence brain neurochemistry and behavior. GOS, for example,
increased hippocampal neurotrophin levels and the expression
N-methyl-d-aspartate receptor subunits in the rat frontal cortex
(Savignac et al., 2013). Behaviorally, a combination of GOS
and polydextrose attenuated anxiety-like behavior in rats and
induced alterations in the gut microbiota composition (Mika
et al., 2014). In the context of IBS, GOS also appeared to
inﬂuence the gut microbiota and improved anxiety scores (Silk
et al., 2009). Furthermore, in healthy adults, administration of
GOS signiﬁcantly decreased the cortisol awakening response
and decreased attentional vigilance to negative vs. positive
information in a dot-probe task compared to placebo (Schmidt
et al., 2015).
Conclusion and Future Perspectives
The area of microbiome research needs to move beyond
purely compositional assessments to understanding the
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TABLE 2 | Preclinical studies of probiotics and intestinal barrier.
Probiotic Effects References
VSL#3 Normalization of colonic physiologic function and barrier integrity; reduction in
mucosal secretion of TNFα and IFNγ and an improvement in histologic disease
Corridoni et al., 2012
Decreased ileal paracellular permeability, decrease claudin-2 and increase occludin in
a mouse model of ileitis
VSL#3 (protein soluble factor) Enhanced barrier function and resistance to Salmonella invasion Madsen et al., 2001
VSL#3 Prevented the increase in epithelial permeability in DSS-induced acute colitis and
prevented the decrease in expression and redistribution of occludin, zonula
occludens-1, and claudin-1, -3, -4, and -5
Mennigen et al., 2009
VSL#3 VSL#3 attenuated intestinal barrier damage and reduced bacterial translocation in an
LPS induced mouse model of sepsis
Ewaschuk et al., 2007
Lactobacillus rhamnosus and L. acidophilus Attenuated the damage caused by Shigella dysenteriae Moorthy et al., 2009
Lactobacillus plantarum Prevented the rearrangement of claudin-1, occludin, JAM-1 and ZO-1 proteins
induced by Escherichia coli
Qin et al., 2009
Lactobacillus reuteri Reduced levels of colonic mucosal adherent and translocated bacteria and
attenuated the development of the colitis in interleukin IL-10 gene deficient mice
Madsen et al., 1999
Lactobacillus rhamnosus GG culture supernatant
(LGG-s)
Pretreatment significantly inhibited alcohol-induced intestinal permeability defects,
endotoxemia and subsequent liver injury
Wang et al., 2012b
Lactobacillus rhamnosus OLL2838 (live and
heat-killed)
Protected against the increase in mucosal permeability associated with DSS-induced
colitis
Miyauchi et al., 2009
Increased expression of ZO-1 and myosin light-chain kinase in intestinal epithelial
cells isolated from mice of the heat-killed OLL2838 group
Lactobacillus casei DN-114 001 (lysate—Lc) Increased the numbers of CD4(+)FoxP3(+) Tregs in mesenteric lymph nodes,
decreased the production of TNFα and IFNγ, and anti-inflammatory IL-10 in Peyer’s
patches and the large intestine; changed the gut microbiota composition in DSS
colitis
Zakostelska et al., 2011
Lc also resulted in a significant protection against increased intestinal permeability
and barrier dysfunction
Lc treatment prevented LPS-induced TNFα expression in RAW 264.7 cell line by
down-regulating the NF-kB signaling pathway
Lactobacillus brevis SBC8803 polyphosphate
(poly P)
Suppressed the oxidant-induced increase in intestinal permeability in the mouse small
intestine
Segawa et al., 2011
Daily intrarectal administration of poly P improved the inflammatory profile and survival
rate when administered to DSS mice
Lactobacillus rhamnosus GG, soluble secretory
proteins p40 and p75
Prevented hydrogen peroxide induced redistribution of occludin, ZO-1, E-cadherin,
and beta-catenin from the intercellular junctions
Seth et al., 2008
Lactobacillus plantarum DSM 2648 Attenuated the negative effect of enteropathic Escherichia coli (EPEC) O127:H6
(E2348/69) on transepithelial electrical resistance and adherence to intestinal cells
Anderson et al., 2010a
Lactobacillus plantarum MB452 19 TJ related genes had altered expression levels including those encoding occludin
and its associated plaque proteins that anchor it to the cytoskeleton
Anderson et al., 2010b
L. plantarum MB452 altered tubulin and proteasome gene expression levels
Lactobacillus acidophilus protects TJ from
aspirin-induced damage in HT-29 cells
Protects TJ from aspirin-induced damage in HT-29 cells Montalto et al., 2004
Lactobacillus rhamnosus GG (LGG) - modified
lipoteichoic acid (LTA)
Correlated with a significant down-regulation of TRL2 expression and downstream
proinflammatory cytokine expression in DSS mouse model
Claes et al., 2010
(Continued)
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TABLE 2 | Continued
Probiotic Effects References
Lactobacillus plantarum 299v Administration for one week abolished E. coli-induced increase in permeability Mangell et al., 2002
Lactobacillus helveticus and Lactobacillus
rhamnosus
Administration one week prior to, and concurrently with, Citrobacter rodentium
attenuated C. rodentium-induced barrier dysfunction, epithelial hyperplasia, and
binding of the pathogen to host colonocytes
Rodrigues et al., 2012
Lactobacillus rhamnosus LOCK0900, L.
rhamnosus LOCK0908 and L. casei LOCK0919
Colonization of GF mice enhanced the integrity of gut mucosa and ameliorated
allergic sensitization
Kozakova et al., 2015
Lactobacillus fermentum AGR1487 - cell surface
structures and supernatant
Live and dead AGR1487 decreased TEER across Caco-2 cells
Only live AGR1487 increased the rate of passage of mannitol
Sengupta et al., 2015
Lactobacillus rhamnosus GG (live or heat-killed) Enteral administration accelerated intestinal barrier maturation and induced claudin 3 Patel et al., 2012
Lactobacillus helveticus R0052 and
Bifidobacterium longum R0175
Reversed the deficits in intestinal permeability and depressive like behaviors post MI Arseneault-Breard
et al., 2012
Bifidobacterium lactis CNCM I-2494 Prevented the increase in intestinal permeability induced by PRS and restored
occludin and JAM-A expressions to control levels
Agostini et al., 2012
Bifidobacteria infantis In T84 cells increased TEER, decreased claudin-2, and increased ZO-1 and occludin
expression, associated with enhanced levels of phospho-ERK and decreased levels
of phospho-p38
Ewaschuk et al., 2008
Prevented TNFα and IFNγ induced decrease in TEER and rearrangement of TJ
proteins
Oral administration acutely reduced colonic permeability in mice whereas long-term
BiCM treatment in IL-10-deficient mice attenuated inflammation, normalized colonic
permeability and decreased colonic and splenic IFN-gamma secretion
Bacteroides thetaiotaomicron Modulated the expression of genes involved in several important intestinal functions,
including nutrient absorption, mucosal barrier fortification, xenobiotic metabolism,
angiogenesis, and postnatal intestinal maturation
Hooper et al., 2001
Escherichia coli Nissle 1917 Altered the expression and distribution of ZO-2 protein Zyrek et al., 2007
Escherichia coli Nissle 1917 Colonization of GF mice resulted in an up-regulation of ZO-1 in intestinal epithelial
cells at both mRNA and protein levels
Ukena et al., 2007
TJ, tight junction; TEER, transepithelial electrical resistance; DSS, dextran sodium sulfate; PRS, partial restraint stress.
potential mechanisms by which dysbiosis contributes to the
pathophysiology of disease. Preclinical research points to a role
of the gut microbiome in brain function and behavior with a
number of potential pathways being investigated. The possibility
that these eﬀects might be mediated by alterations in intestinal
permeability is supported by converging lines of evidence.
This includes evidence linking stress to both compromised
barrier function and microbiota disruption with the ensuing
systemic inﬂammation mediating the impact on the expression
of neuropsychiatric symptoms (see Figure 2). This hypothesis
needs to be elaborated in preclinical and clinical studies to
establish the relevance of this proposed mechanism. Such
studies will identify whether targeting the epithelial barrier is a
viable strategy in managing stress-related disorders, given the
established role for the gut microbiota in maintaining barrier
function. Indeed, there is growing evidence that certain probiotic
strains as well as prebiotics can beneﬁt barrier function, albeit
largely in healthy controls or non-psychiatric populations
including stress-related GI disorders. However, the success of
this strategy will be contingent on identifying sub groups of
patients with a compromised epithelial barrier who may be
more likely to respond to probiotics with barrier enhancing
eﬀects. Alternative approaches such as psychobiotics may target
other brain-gut axis pathways independent of any eﬀect on
the intestinal barrier. Intervention studies utilizing therapeutic
modulation of the gut microbiota or its metabolites to restore
“normal” intestinal permeability will may be of beneﬁt in
stress-related disorders. As we discussed throughout this review,
the impact of a variety of factors implicated in barrier function,
such as SCFAs, could also produce their eﬀects at higher centers
independently of a compromised intestinal barrier. One clear
example of a distinct alternative signaling mechanism between
the gut microbiota and the CNS is via the vagus nerve (Bravo
et al., 2011). In addition to the disorders mentioned in this
review, preclinical evidence suggests that the gut microbiota
modulates behaviors associated with neurodevelopmental
disorders such as autism spectrum disorder and schizophrenia
(Hsiao et al., 2013; Desbonnet et al., 2014; Mayer et al., 2014b).
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FIGURE 2 | Potential neuropsychiatric consequences of a dysregulated intestinal barrier. Activation of brain-gut-microbiota Axis signaling pathways via a
compromised intestinal barrier with potential effects on mood, anxiety, cognition and social interaction.
However, the clinical implications and the role of the intestinal
barrier have yet to be fully established (Julio-Pieper et al., 2014;
Mayer et al., 2015). We acknowledge that the associations
between a “leaky gut” and stress-related psychiatric disorders
are not without controversy and the narrative surrounding
the impact of the gut microbiome on the CNS requires
further development, both mechanistically and with respect to
translation from promising preclinical ﬁndings to solid clinical
relevance. Integrating these important observations within the
theoretical framework of this review may provide the impetus
to clearly establish the clinical signiﬁcance of these intriguing
concepts and the potential inherent in this ﬁeld supports further
investment and concerted eﬀorts in this area. This success of
this investigation holds promise for novel treatment options
and preventative plans to support good mental health and
to counteract the negative consequences of excessive stress
loads.
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